Sanjeet S. Sehmi
Evotec (United Kingdom)(GB)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Mast cells and histamine, Nicotinic Acetylcholine Receptors Study, Cholinesterase and Neurodegenerative Diseases, Asthma and respiratory diseases
Most-Cited Works
- → Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease(2004)36 cited
- → Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists(2013)25 cited
- → (1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: Further optimisation as highly potent and selective MSK-1-inhibitors(2005)24 cited
- → 4-Acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a Novel Class of Non-Brain-Penetrant Histamine H3 Receptor Antagonists(2007)24 cited
- → Potent oxadiazole CGRP receptor antagonists for the potential treatment of migraine(2010)10 cited
- → The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement(2012)9 cited
- → The discovery of the benzazepine class of histamine H3 receptor antagonists(2013)6 cited
- → Identification of a series of 1,3,4-oxadiazol-2-amines as potent alpha-7 agonists with efficacy in the novel object recognition model of cognition(2012)3 cited
- → A06 Chdi-00340246, A Kynurenine Monooxygenase Inhibitor As Potential Therapeutic Agent For The Treatment Of Huntington's Disease(2014)